Barclays Downgrades Sarepta Therapeutics (SRPT) to Equalweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. COHR
3. CBRS
4. WYFI
5. EAT
6. SPY
7. GO
8. STUB
9. NVDA
10. ANDG

Go back to Barclays Downgrades Sarepta Therapeutics (SRPT) to Equalweight
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 18.60 +0.22 (1.20%)
Previous Close $18.38    52 Week High $63.73 
Open $18.41    52 Week Low $8.00 
Day High $18.73    P/E N/A 
Day Low $18.20    EPS $-5.69 
Volume 427,272